Premium
P3‐037: CLINICAL TRIAL DESIGN FOR A PHASE II, RANDOMIZED, PLACEBO‐CONTROLLED TRIAL OF AMX0035 IN ALZHEIMER'S DISEASE
Author(s) -
Leslie Kent L.,
Cohen Joshua,
Klee Justin,
Williams Victoria,
Arnold Steven E.
Publication year - 2018
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2018.06.1392
Subject(s) - medicine , tolerability , neurodegeneration , placebo , disease , oncology , pathology , adverse effect , alternative medicine